Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on August 25, 2025
Groundswell Community Mural Project Partners with CABS Health Network to Celebrate Care and Community
BROOKLYN, NY, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- Groundswell Community Mural Project, a Brooklyn-based nonprofit empowering youth through public art, is proud to unveil a vibrant two-wall mural at the CABS Health Network office that …
Creative Bioarray Launches High-throughput ADME Screening Service to Accelerate Drug Development
NEW YORK CITY, NY, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- Creative Bioarray, one of the world’s leading biotechnology products and services providers, striving to exceed the expectations by consistently delivering results with exceptional …
Shahidon ko Shraddhanjali' - Indian 79th Independence Day Celebrated in Long Island, New York
Shahidon ko Shraddhanjali” - Indian 79th Independence Day Celebrated with Pride in Long Island, New York by Navika Capital Group and Indian Community UNIONDALE, NY, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- The Indian community of Long Island …
Hydreight Achieves 33% YoY H1 Revenue Growth, Records 3rd Consecutive Quarter of Profitability, and Strengthens Performance Across Verticals
“We had a great first 6 months, with 33% year-over-year growth. We have also exceeded our internal metrics across all verticals in the first seven months of the year, reinforcing the strength of our strategy. A key focus has been our investment in making …
Start-up StudyConnect Launches a New Era of Medical Professional Networking
Study Connect Inc./Albany, NY/ 25 Aug 2025 - Welcomes a new era of collaboration for medical professionals with a fresh look at communities and communication. ALBANY, NY, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- StudyConnect today announced …
CoachCare Appoints Raymond Parvin as Chief Operating Officer to Drive Next Phase of Growth and Operational Excellence
New executive leader brings decades of experience in scaling global medical device operations and advancing healthcare innovation NEW YORK, NY, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- CoachCare, a leading provider of remote patient …
ANI Pharmaceuticals to Present at Upcoming Investor Conferences
PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team …
Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway
- U.S. IND filing planned for Q4 2025 with U.S. enrollment expected to start in Q1 2026 - Patient dosing expected to begin in Australia in Q4 2025 HUNTSVILLE, AL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), …
Memgen Announces First Patient Dosed in Phase 1 Combination Cohort of MEM-288 Plus Docetaxel in Advanced Non–Small Cell Lung Cancer
TAMPA, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Memgen, Inc., a clinical-stage biotechnology company developing oncolytic immunotherapy for solid tumors, today announced the dosing of the first patient in its Phase 1 combination cohort evaluating …
Option Care Health To Participate in Upcoming Investor Conferences
BANNOCKBURN, Ill., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor …
Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025
SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases …
RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference
ALISO VIEJO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in …
OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors
WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to …
Kyverna Therapeutics to Present at Upcoming Investor Conferences in September
EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, …
Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, today announced its participation in the …
Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025
MP0533 data presented at European Hematology Association (EHA) highlights improved response rates and antitumor activity in low disease burden patients; additional data under amended dosing scheme expected in Q4 2025 IND filing on first radio-DARPin …
Tevogen Sees Continued Growth in Institutional Ownership in Q2 2025; 72% of Holders Increased or Maintained Positions
WARREN, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding common stock, as reported by institutional investment …
MBW RCM Recognized as a Great Place to Work® for 2025–2026, Second Year in a Row
MBW RCM earns Great Place to Work® Certification for 2025–2026, marking its second consecutive year of recognition for workplace excellence. MONSEY, NY, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- MBW RCM, a healthcare revenue cycle management …
Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight
New York, USA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight Insmed’s BRINSUPRI (brensocatib) has reached a significant regulatory milestone, earning FDA …